[A Case of Primary Amelanotic Malignant Melanoma of the Esophagus, Wherein Pseudoprogression Was Suspected during Immune Checkpoint Inhibitor Treatment].

Matsumoto, Yasunori; Hirasawa, Soichiro; Natsume, Toshiyuki; Kainuma, Osamu; Tanaka, Hajime; Toyozumi, Takeshi; Murakami, Kentaro; Matsubara, Hisahiro; Maruyama, Takashi

Matsumoto, Yasunori; Hirasawa, Soichiro; Natsume, Toshiyuki; Kainuma, Osamu; Tanaka, Hajime; Toyozumi, Takeshi; Murakami, Kentaro; Matsubara, Hisahiro; Maruyama, Takashi.

Affiliation

Matsumoto Y; Dept. of Surgery, Funabashi Municipal Medical Center.

Gan To Kagaku Ryoho ; 47(8): 1251-1253, 2020 Aug.

Article in Ja | MEDLINE | ID: mdl-32829366

Subject(s)

Esophageal Neoplasms; Melanoma, Amelanotic; Aged; Esophageal Neoplasms/drug therapy; Humans; Male; Melanoma, Amelanotic/drug therapy; Nivolumab

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Melanoma, Amelanotic Type of study: Guideline Limits: Aged / Humans / Male Language: Ja Journal: Gan To Kagaku Ryoho Year: 2020 Type: Article

Search on Google

XML

PubMed Links